On May 1, 2009, there had been a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that people using the products were developing serious liver issues and other health issues. Less than seven days later, on May 4, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Case alleges company negligence in informing the public about potential perils of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it did not reveal to consumers, it should definitely be held accountable.
A class action court action is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less pricey, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost anything unless there is a settlement. At that point, the attorney who handled the suit will take his costs from the compensation that was given and then share the leftover funds to the litigants in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the explanations that class action legal actions became so popular.
The first class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall happened in the United States where twenty-three cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning people who sustained respiratory, neurological, cardiovascular, and gastrointestinal problems as a consequence of Canadians using the products.
The Hydroxycut Liver Damage Suits alleges that the company sold the products without properly informing the public of the health risks that they could exposing buyers to. The complaint states the company failed to publish the information on the product labels stating that users could run the chance of liver and kidney damage as well as stomach, heart, respiration, and neurological problems. The suit goes on to claim this was an obvious omission on the part of the company which purposely misled clients concerning the protection of the products.












Sorry, the comment form is closed at this time.